CF
GILD icon

Claris Financial’s Gilead Sciences GILD Stock Holding History

Claris Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$422K Buy
3,028
+3
+0.1% +$420 0.23% 97
2025
Q4 		$371K Buy
3,025
+332
+12% +$40.3K 0.2% 108
2025
Q3 		$299K Buy
+2,693
New +$306K 0.17% 122

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Claris Financial's GILD Position: Q1 2026 in Review

Claris Financial increased its Gilead Sciences (GILD) stake by 0.1% in Q1 2026, buying an estimated $420 and bringing the position to 3,028 shares worth $422K. The position accounts for 0.23% of the portfolio, ranked #97.

Claris Financial first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Claris Financial held 3,028 shares of Gilead Sciences worth $422K as of Q1 2026.
  • Claris Financial bought 3 Gilead Sciences shares in Q1 2026, an estimated $420.
  • Gilead Sciences made up 0.23% of Claris Financial's portfolio in Q1 2026, its #97 holding.
  • Claris Financial first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Claris Financial's 13F filing for Q1 2026, filed 18 May 2026.